These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34990968)

  • 1. Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance - Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase.
    Ahmadpanah M; Pezeshki R; Soltanian AR; Jahangard L; Dürsteler KM; Keshavarzi A; Brand S
    J Psychiatr Res; 2022 Feb; 146():163-171. PubMed ID: 34990968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Keshavarzi A; Sharifi A; Jahangard L; Soltanian A; Brühl AB; Ahmadpanah M; Brand S
    Neuropsychobiology; 2022; 81(3):192-203. PubMed ID: 34979513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial.
    Keshavrzi A; Rezaei H; Haghighi M; Jahangard L
    Neuropsychobiology; 2019; 78(4):200-208. PubMed ID: 31315114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial.
    Abedini T; Hosseyni R; Ghannadi F; Moghaddam HS; Ardakani MK; Talaei A; Akhondzadeh S
    Psychiatry Clin Neurosci; 2022 Oct; 76(10):505-511. PubMed ID: 35737597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
    Machado-Vieira R; Soares JC; Lara DR; Luckenbaugh DA; Busnello JV; Marca G; Cunha A; Souza DO; Zarate CA; Kapczinski F
    J Clin Psychiatry; 2008 Aug; 69(8):1237-45. PubMed ID: 18681754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
    Akhondzadeh S; Mohajari H; Reza Mohammadi M; Amini H
    BMC Psychiatry; 2003 Jun; 3():7. PubMed ID: 12816549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.
    Badrfam R; Mostafavi SA; Khaleghi A; Akhondzadeh S; Zandifar A; Farid M; Mohammadian Khonsari N; Mohammadi MR
    Brain Behav; 2021 Nov; 11(11):e2394. PubMed ID: 34662000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
    J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
    Potkin SG; Keck PE; Segal S; Ice K; English P
    J Clin Psychopharmacol; 2005 Aug; 25(4):301-10. PubMed ID: 16012271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran.
    Faridhosseini F; Talaei A; Shahini N; Salimi Z; Eslamzadeh M; Ahrari S; Pourgholami M; Khadem-Rezaiyan M
    Int Clin Psychopharmacol; 2023 Sep; 38(5):336-341. PubMed ID: 37159172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
    J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder.
    Jahangard L; Soroush S; Haghighi M; Ghaleiha A; Bajoghli H; Holsboer-Trachsler E; Brand S
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1210-21. PubMed ID: 24953766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.